Welcome To The Mannkind HUB On AGORACOM
Edit this title from the Fast Facts Section
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

AGORACOM News Flash

VIDEO - FRESH OFF THE WEBCAM - AGORACOM SMALL CAP BEST OF THE BEST - OCTOBER 29, 2014

George and Allan Discuss:

  • The TSX Venture Exchange
  • Top Small Cap Stock Picks
  • Buy Now or Wait ... Tax Loss Selling Strategies

WHAT ARE SMALL CAP INVESTORS SAYING?

"Thank-You Very Much. I Love The Show. I Discovered You Guys A Couple Of Days Ago And Will Now Become A Regular Viewer!" (Sean Reid)

CLICK ON IMAGE BELOW TO WATCH WHAT YOU'VE BEEN MISSING!



Message: Afrezza sales could be higher than Exubera, says Summer Street

Barney-fife-crop-fix
Rank: [?]
President
Points: [?]
5492
Rating: [?]
Votes: 21 Score: 4.5
  • Currently 4.5/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

Afrezza sales could be higher than Exubera, says Summer Street

posted on Jul 16, 13 09:52AM

"Summer Street believes that if approved, sales of MannKind's (MNKD) inhalable insulin Afrezza could be "substantially higher" than Pfizer’s (PFE) Exubera given Afrezza’s ease of use. However, the firm adds that it cannot accurately predict future sales of Afrezza at this time."

http://www.theflyonthewall.com/permalinks/entry.php/MNKD;PFEid1858409/MNKD;PFE-Afrezza-sales-could-be-higher-than-Exubera-says-Summer-Street

New Message

Please login to post a reply

AGORACOM Quick Tips

AGORACOM Twitter. Follow our small but powerful market tips .. Follow and Prosper

President's D.D.

Here's the latest Griffin report read more

Stock Quote

Hub Leaders